PREDNISONE INTENSOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prednisone Intensol, and when can generic versions of Prednisone Intensol launch?
Prednisone Intensol is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in PREDNISONE INTENSOL is prednisone. There are sixteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the prednisone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prednisone Intensol
A generic version of PREDNISONE INTENSOL was approved as prednisone by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PREDNISONE INTENSOL?
- What are the global sales for PREDNISONE INTENSOL?
- What is Average Wholesale Price for PREDNISONE INTENSOL?
Summary for PREDNISONE INTENSOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 72 |
Patent Applications: | 3,966 |
Drug Prices: | Drug price information for PREDNISONE INTENSOL |
DailyMed Link: | PREDNISONE INTENSOL at DailyMed |
Recent Clinical Trials for PREDNISONE INTENSOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mamta Parikh | Phase 2 |
Children's Oncology Group | Phase 2 |
Mayo Clinic | Phase 2 |
Pharmacology for PREDNISONE INTENSOL
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for PREDNISONE INTENSOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | PREDNISONE INTENSOL | prednisone | SOLUTION;ORAL | 088810-001 | Feb 20, 1985 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |